Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
26M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
5.97M
-
Shares change
-
-434K
-
Total reported value, excl. options
-
$60.9M
-
Value change
-
-$4.44M
-
Put/Call ratio
-
0.2
-
Number of buys
-
26
-
Number of sells
-
-23
-
Price
-
$10.22
Significant Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q3 2025
71 filings reported holding RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK as of Q3 2025.
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.97M shares
of 26M outstanding shares and own 22.98% of the company stock.
Largest 10 shareholders include FMR LLC (2.16M shares), BlackRock, Inc. (649K shares), Siren, L.L.C. (563K shares), VANGUARD GROUP INC (521K shares), MPM BIOIMPACT LLC (380K shares), Erste Asset Management GmbH (260K shares), GEODE CAPITAL MANAGEMENT, LLC (242K shares), 683 Capital Management, LLC (230K shares), STATE STREET CORP (198K shares), and NORTHERN TRUST CORP (91.3K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.